<DOC>
	<DOC>NCT01110954</DOC>
	<brief_summary>This is an explorative phase II study to investigate the suitability of PD L 506 in the specific intra-operative detection of breast tumour tissue.</brief_summary>
	<brief_title>Fluorescence-guided Resection in Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Written informed consent Caucasian female postmenopausal patients Patients with histologically confirmed primary palpable and nonpalpable breast cancer sized up to 5 cm (T1 T2) Suspicious lymphogenic metastases (cN13) Acute or chronic hepatic diseases Manifest renal diseases with renal dysfunction Relevant cardiac disease Preceding therapy of breast tumour under investigation Patients with multiple attempts of hookwire placement in preparation of surgery Dementia or psychic condition that might interfere with the ability to understand the study and thus give a written informed consent Simultaneous participation in another clinical study or participation in another clinical study in the 30 days directly preceding treatment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>